14-day Premium Trial Subscription Try For FreeTry Free
$4.96
+0.0100 (+0.202%)
At Close: May 07, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
Date Action Amount Person Type
Apr 01, 2024 Buy 62 500 Snow Jessica Stock Options (Right to buy)
Apr 01, 2024 Buy 31 250 Snow Jessica Common Stock
Apr 01, 2024 Buy 42 500 Eatwell Victoria Common Stock
Apr 01, 2024 Buy 85 000 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 56 250 Baird William D Iii Common Stock
Apr 01, 2024 Buy 112 500 Baird William D Iii Stock Options (Right to buy)
Apr 01, 2024 Buy 0 Eatwell Victoria Common Stock
Apr 01, 2024 Buy 491 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 344 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 2 098 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 9 000 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 21 700 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 11 830 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 1 542 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 377 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 271 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 655 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 738 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 417 Eatwell Victoria Stock Options (Right to buy)
Apr 01, 2024 Buy 0 Snow Jessica Common Stock
Apr 01, 2024 Buy 990 Snow Jessica Stock Options (Right to buy)
Apr 01, 2024 Buy 425 Snow Jessica Stock Options (Right to buy)
Apr 01, 2024 Buy 491 Snow Jessica Stock Options (Right to buy)
Apr 01, 2024 Buy 343 Snow Jessica Stock Options (Right to buy)
Apr 01, 2024 Buy 2 098 Snow Jessica Stock Options (Right to buy)
Apr 01, 2024 Buy 9 500 Snow Jessica Stock Options (Right to buy)
Apr 01, 2024 Buy 18 300 Snow Jessica Stock Options (Right to buy)
Apr 01, 2024 Buy 6 400 Snow Jessica Stock Options (Right to buy)
Mar 26, 2024 Buy 40 000 Casdin Capital, Llc Common Stock, par value $0.0001 per share
Mar 25, 2024 Buy 330 000 Casdin Capital, Llc Common Stock, par value $0.0001 per share
Mar 22, 2024 Buy 147 377 Casdin Capital, Llc Common Stock, par value $0.0001 per share
Mar 21, 2024 Buy 300 000 Casdin Capital, Llc Common Stock, par value $0.0001 per share
Mar 21, 2024 Sell 63 151 Casdin Capital, Llc Total Return Swap
Mar 20, 2024 Buy 0 Casdin Capital, Llc Common Stock, par value $0.0001 per share
Mar 20, 2024 Buy 0 Casdin Capital, Llc Common Stock, par value $0.0001 per share
Mar 20, 2024 Buy 33 400 Casdin Capital, Llc Stock Options (Right to buy)
Mar 20, 2024 Buy 599 935 Casdin Capital, Llc Total Return Swap
Mar 20, 2024 Buy 33 400 Newton Charles W. Stock Options (Right to buy)
Mar 20, 2024 Buy 16 600 Newton Charles W. Common Stock
Mar 20, 2024 Buy 0 Newton Charles W.
Jan 08, 2024 Buy 91 000 Baird William D Iii Common Stock
Jan 08, 2024 Buy 182 000 Baird William D Iii Stock Option (Right to buy)
Jan 08, 2024 Buy 79 438 Gregory Philip D Common Stock
Jan 08, 2024 Buy 158 875 Gregory Philip D Stock Option (Right to buy)
Jan 08, 2024 Buy 235 000 Leschly Nick Common Stock
Jan 08, 2024 Buy 469 000 Leschly Nick Stock Option (Right to buy)
Jan 05, 2024 Sell 1 380 Baird William D Iii Common Stock
Jan 05, 2024 Sell 795 Gregory Philip D Common Stock
Jan 05, 2024 Sell 1 554 Leschly Nick Common Stock
Jan 03, 2024 Sell 72 312 Leschly Nick Common Stock
Jan 03, 2024 Sell 25 613 Gregory Philip D Common Stock
Jan 03, 2024 Sell 33 651 Baird William D Iii Common Stock
Aug 22, 2023 Sell 9 312 Leschly Nick Common Stock
Aug 22, 2023 Sell 6 159 Gregory Philip D Common Stock
Aug 22, 2023 Sell 7 031 Baird William D Iii Common Stock
Aug 10, 2023 Buy 100 000 Kynam Global Healthcare Master Fund, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 100 000 Kynam Global Healthcare Master Fund, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 50 000 Kynam Global Healthcare Master Fund, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 179 000 Kynam Global Healthcare Master Fund, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 86 414 Kynam Global Healthcare Master Fund, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 0 Kynam Global Healthcare Master Fund, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 0 Kynam Global Healthcare Master Fund, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 0 Kynam Global Healthcare Master Fund, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 100 000 Kynam Capital Management, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 100 000 Kynam Capital Management, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 50 000 Kynam Capital Management, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 179 000 Kynam Capital Management, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 86 414 Kynam Capital Management, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 0 Kynam Capital Management, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 0 Kynam Capital Management, Lp Common Stock, par value $0.0001 per share
Aug 10, 2023 Buy 0 Kynam Capital Management, Lp Common Stock, par value $0.0001 per share
Aug 03, 2023 Sell 9 060 Leschly Nick Common Stock
Aug 03, 2023 Sell 3 966 Gregory Philip D Common Stock
Aug 03, 2023 Sell 6 906 Baird William D Iii Common Stock
Jun 13, 2023 Buy 8 400 Ibrahim Ramy Common Stock
Jun 13, 2023 Buy 16 900 Ibrahim Ramy Stock Option (right to buy)
Jun 13, 2023 Buy 8 400 Torres Denice Common Stock
Jun 13, 2023 Buy 16 900 Torres Denice Stock Option (right to buy)
Jun 13, 2023 Buy 16 900 Maus Marcela V. Stock Option (right to buy)
Jun 13, 2023 Buy 8 400 Maus Marcela V. Common Stock
Jun 13, 2023 Buy 16 900 Glickman Sarah Js Stock Option (right to buy)
Jun 13, 2023 Buy 8 400 Glickman Sarah Js Common Stock
Jun 13, 2023 Buy 8 400 Lynch Daniel Common Stock
Jun 13, 2023 Buy 16 900 Lynch Daniel Stock Option (right to buy)
Jun 13, 2023 Buy 4 200 Wei Lin Common Stock
Jun 13, 2023 Buy 8 450 Wei Lin Stock Option (right to buy)
Mar 07, 2023 Buy 33 400 Wei Lin Stock Option (Right to buy)
Mar 07, 2023 Buy 16 600 Wei Lin Common Stock
Mar 07, 2023 Buy 0 Wei Lin
Feb 13, 2023 Sell 637 Baird William D Iii Common Stock
Feb 07, 2023 Sell 60 Heffron Nicola Common Stock
Feb 01, 2023 Buy 142 857 Gregory Philip D Common Stock
Feb 01, 2023 Buy 25 000 Gregory Philip D Common Stock
Feb 01, 2023 Buy 50 000 Gregory Philip D Stock Option (Right to buy)
Feb 01, 2023 Buy 107 143 Baird William D Iii Common Stock
Feb 01, 2023 Buy 25 000 Baird William D Iii Common Stock
Feb 01, 2023 Buy 50 000 Baird William D Iii Stock Option (Right to buy)
Feb 01, 2023 Buy 428 571 Leschly Nick Common Stock
Feb 01, 2023 Buy 81 250 Leschly Nick Common Stock
Feb 01, 2023 Buy 162 500 Leschly Nick Stock Option (Right to buy)
JSON CSV
INSIDER POWER
86.104
Last 100 transactions
Buy: 5 486 334 | Sell: 241 587 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 86.104.

In total, the insiders bought 5 486 334 and sold 241 587 TSVT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About 2seventy bio, Inc.

2seventy bio. 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is h... TSVT Profile

Golden Star

Ticker Date Change Price
BBCA May 03 1.26% $65.44
ADTH May 03 5.56% $3.24
ISTB May 03 0.0425% $47.11
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
INVH May 03 1.72% $34.39
INTU May 03 1.89% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT